Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses

被引：0
|
作者：
ten Haaf, Kevin [1 ]
de Koning, Harry J. [1 ]
机构：
[1] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
来源：
JAMA ONCOLOGY | 2016年 / 2卷 / 02期
关键词：
D O I：
10.1001/jamaoncol.2015.4457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 278
页数：3
相关论文
共 50 条
  • [41] Rehabilitation after stroke: Cost-effectiveness analyses
    Keith, RA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1996, 89 (11) : 631 - 633
  • [42] Assessment of disutility in cost-effectiveness analyses in acne
    Sun, Helen Y.
    Sebaratnam, Deshan F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (03) : 242 - 243
  • [43] Cost-effectiveness analyses of statistically ineffective treatments
    Trippoli, S
    Messori, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (23): : 1992 - 1992
  • [44] A primer on cost-effectiveness analyses for vascular surgeons
    Barshes, Neal R.
    Chambers, James D.
    Cantor, Scott B.
    Cohen, Joshua
    Belkin, Michael
    JOURNAL OF VASCULAR SURGERY, 2012, 55 (06) : 1794 - 1800
  • [45] Cost-effectiveness analyses: Making a pseudoscience legitimate
    Rennie, D
    JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2001, 26 (02) : 383 - 386
  • [46] Future drug prices and cost-effectiveness analyses
    Hoyle, Martin
    PHARMACOECONOMICS, 2008, 26 (07) : 589 - 602
  • [47] Reporting cost-effectiveness analyses with confidence - Reply
    Siegel, JE
    Weinstein, MC
    Fryback, DG
    Manning, WG
    Torrance, GW
    Russell, LB
    Gold, MR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (05): : 375 - 375
  • [48] Cost-effectiveness analyses of total ankle arthroplasty
    SooHoo, NF
    Kominski, G
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2004, 86A (11): : 2446 - 2455
  • [49] STANDARDS FOR COST-EFFECTIVENESS ANALYSES IN THE CONTEXT OF DISSEMINATION
    Riley, William
    ANNALS OF BEHAVIORAL MEDICINE, 2018, 52 : S431 - S431
  • [50] Future Drug Prices and Cost-Effectiveness Analyses
    Martin Hoyle
    PharmacoEconomics, 2008, 26 : 589 - 602
12345